London et al reported PAD to be associated with low bone turnover and pronounced osteoblast resistance to PTH in non-diabetic dialysis-dependent ESRD patient [30], which provided a light for possible explanation PTX may be protective for occurrence of PAD. This evidence concerns the gene PTH and peripheral arterial disease.